查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873993

生物膜治疗市场

Biofilms Treatment Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024年，生物膜治疗市场价值约为22.9亿美元，预计到2031年将成长至38.8亿美元。该市场预计在2031年至2032年间将经历8.0%的年复合成长率（CAGR）。推动生物膜治疗市场发展的关键趋势包括产品发布、审批和技术进步等策略性倡议。

生物膜治疗市场分析

伤口和感染的日益增多，以及医疗器材上生物膜的不断增殖，推动了对生物膜治疗的需求，从而促进了全球市场成长。此外，生物膜的日益普遍预计将在预测期内进一步推动市场扩张。研究表明，60%至100%的慢性伤口样本中都存在生物膜，凸显了生物膜在慢性伤口中快速且广泛的存在，因此亟需有效的治疗方案。技术进步、创新产品的推出以及新市场参与者的涌入现有望促进全球市场成长。然而，生物膜相关感染的增加、抗生素抗药性、高昂的成本以及先进伤口护理产品普及率有限等挑战可能会阻碍市场的整体发展。

生物膜治疗市场概览

医疗保健支出不断增长、人口老化导致慢性伤口易感性增加、新产品上市以及有利的报销政策等因素正在推动市场成长。监管机构日益重视生物膜相关感染的公共卫生影响，并制定了旨在预防和治疗此类感染的严格法规和指南，这反过来又促进了对符合规范的生物膜治疗方案的需求。各公司正积极寻求技术创新，以期在传统方法的基础上提升生物膜治疗效果。这些创新可能包括：研发具有增强抗菌性能的先进伤口敷料；将智慧材料应用于生物膜的检测和管理；以及开发靶向药物递送系统以对抗生物膜内的细菌。此外，研究人员正在利用包括生物技术和奈米技术在内的新技术，开发更有效、更有效率的生物膜治疗方案。

战略洞察

生物膜治疗市场驱动因素与机会

慢性伤口、手术伤口和创伤性伤口发生率的增加将有利于市场发展

根据国际糖尿病联盟的研究，2024年全球糖尿病盛行率约为9.3%，影响约4.63亿人，预计2030年将上升至10.2%（约5.78亿人）。生物膜对囊性纤维化（CF）患者的肺部和消化系统也有显着影响，全球有超过7万人受其影响，其中约3万人在美国。 CF肺部的生物膜对抗生素治疗具有显着的抗药性，这加剧了CF带来的巨大经济负担，估计每年高达75.09亿美元。此外，医疗技术的进步导致外科手术数量增加，美国每年约进行2,700万例手术，其中约5%会导致手术部位感染。

新兴经济体研究的不断成长—为生物膜治疗市场成长带来机会

各领域对微生物生物膜作用的认识不断提高，为转化研究中创新技术的开发带来了新的机会，旨在减轻其不利影响并发挥其益处。目前的研究重点是开发可与抗生素合併使用的新型化合物以对抗感染。创新策略对于预防和消除具有临床意义的感染至关重要，尤其是在奈米尺度上。了解生物膜促进感染和抗生素抗药性的机制，对于开发治疗医院获得性病原体感染的有效方法至关重要。能够同时进行诊断和治疗的先进多功能奈米材料的合成在当代研究中日益受到关注。转录组学、代谢组学和基于转座子的下一代定序技术的进步，有望发现生物膜研究的新基因标靶。

此外，迫切需要发现能够针对生物膜特定成分的新型抗生物膜药物。基于奈米颗粒的抗生物膜药物研究正成为一个极具前景的领域，尤其是在联合使用多种药物的情况下。 2021年4月，密西根州立大学（MSU）获得了默多克信託基金提供的51.3万美元资助，从而增强了其生物膜研究能力。因此，正在进行的研究有望对生物膜治疗产生积极影响，并为市场成长创造有利可图的机会。

生物膜治疗市场报告細項分析

生物膜治疗市场分析按产品、伤口类型和最终用户进行细分。

  • 依产品划分，市场可分为清创设备、纱布和敷料、植皮和基质等产品。纱布和敷料细分市场在2023年占据最大的市场份额，预计在预测期内将保持最高的复合年增长率。
  • 依伤口类型划分，市场可分为创伤和手术伤口、糖尿病足溃疡、压疮、静脉性腿部溃疡和其他伤口。创伤和手术伤口细分市场在2023年占据最大市场份额，预计在2023年至2031年期间将保持最高的复合年增长率。
  • 从终端用户角度来看，市场可细分为医院、家庭护理机构和其他终端用户。医院细分市场在2023年占据了最大的市场份额，预计在预测期内将保持最高的复合年增长率。

生物膜治疗市场份额按地域划分分析

生物膜治疗市场的地理分析分为五个区域：北美、亚太、欧洲、中东和非洲以及南美/南美和中美洲。

北美在生物膜治疗市场占据领先地位，这主要得益于糖尿病盛行率的上升以及众多提供伤口护理解决方案的机构的存在。北美生物技术产业在推进生物膜治疗方面发挥着至关重要的作用。与全球平均值相比，美国糖尿病（DM）的盛行率已达到流行病等级。随着糖尿病患者数量的增加，相关併发症也随之增加。许多机构和出版物都制定了治疗和闭合糖尿病足溃疡（DFU）的建议做法。然而，儘管有这些指南，美国祇有50%的DFU能在一年内癒合。加拿大伤口协会（Wounds Canada，前身为加拿大伤口护理协会）是一家致力于推动加拿大伤口预防和管理的非营利组织，其工作重点包括教育、研究、宣传和合作。墨西哥伤口护理与癒合协会是一个非营利组织，由一群致力于研究墨西哥伤口和造口的多学科专家组成，旨在促进全面的护理和治疗，以提高患者的生活品质。预计未来几年亚太地区的复合年增长率将最高。

生物膜治疗市场报告范围

生物膜治疗市场新闻及最新进展

生物膜治疗市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。生物膜治疗市场的最新发展包括：

  • 囊性纤维化基金会向 Clarametyx Biosciences 公司投资高达 500 万美元，用于开发 CMTX-101 药物。 CMTX-101 是一种旨在治疗难治性细菌感染的药物，例如慢性绿脓桿菌感染，而绿脓桿菌是囊性纤维化患者肺部感染的主要原因之一。 （囊性纤维化基金会，新闻，2024 年）
  • 专注于发现和开发天然人源单株抗体的生物技术公司Trellis Bioscience Inc.宣布，其主要候选抗体TRL1068已获得美国食品药物管理局（FDA）的快速通道和合格传染病产品（QIDP）资格认定。 （资料来源：Trellis Bioscience, Inc.，新闻稿，2024）
  • ASEP医疗控股公司宣布，已利用人工智慧（AI）开发出针对常见生物膜感染的新型改良疗法以及用于快速诊断败血症的方法。 （资料来源：ASEP医疗控股公司，新闻稿，2024年）
  • Medline 和 OMNIA Partners 宣布建立新的采购合作伙伴关係，旨在为包括州、县和地方政府、中小学和高等教育系统以及公共安全服务机构在内的公共部门机构提供医疗外科产品组合方面的成本节约方案，使其能够获得 Medline 超过 30 万种医疗用品的丰富产品组合。 （Medline Industries, LP，新闻稿，2022 年）

生物膜治疗市场报告涵盖范围及成果

题为《生物膜治疗市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态，例如驱动因素、限制因素和关键机会
  • 未来主要趋势
  • 详细的PEST/波特五力模型与SWOT分析
  • 全球及区域市场分析，重点在于关键市场趋势、主要参与者、法规及最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 公司详细概况

目录

第一章：引言

第二章：生物膜治疗市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球生物膜治疗及市场概况

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲和PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 专家意见

第五章：生物膜治疗市场及主要市场动态

  • 市场驱动因素
    • 慢性伤口、手术伤口和创伤性伤口的发生率不断上升
    • 烧伤病例数不断增加
  • 市场限制
    • 伤口治疗费用高昂
  • 市场机会
    • 新兴经济体对生物膜治疗的研究日益增多
  • 未来趋势
    • 新技术的开发
  • 影响分析

第六章：生物膜治疗市场及全球分析

  • 全球生物膜治疗市场收入预测与分析
  • 全球生物膜治疗市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：生物膜治疗市场分析及产品分类

  • 概述
  • 生物膜治疗市场收入份额（按产品划分，2024 年和 2031 年）
  • 清创装置
  • 纱布和敷料
  • 移植和基质
  • 其他产品

第八章：生物膜治疗市场分析及依伤口类型划分

  • 概述
  • 生物膜治疗市场收入份额（按应用领域划分，2024 年和 2031 年）
  • 创伤与手术伤口
  • 糖尿病足溃疡
  • 压疮
  • 静脉性腿部溃疡
  • 其他伤口

第九章：生物膜治疗市场分析及最终用户细分

  • 概述
  • 2024 年和 2031 年生物膜治疗市场份额（按最终用户划分，%）
  • 医院
  • 家庭护理机构
  • 其他最终用户

第十章：生物膜治疗市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十一章：新冠疫情对全球生物膜治疗市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 世界其他地区

第十二章：生物膜治疗市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十三章：公司简介

  • Smith and Nephew

第十四章：附录

简介目录
Product Code: TIPRE00015873

In 2024, the biofilms treatment market was valued at approximately US$ 2.29 billion and is anticipated to grow to US$ 3.88 billion by 2031. The market is projected to experience a compound annual growth rate (CAGR) of 8.0% from 2031 to 2031. Key trends driving the biofilms treatment market include strategic initiatives such as product launches, approvals, and advancements in technology.

Biofilms Treatment Market Analysis

The rising occurrence of wounds and infections, along with the proliferation of biofilms on medical devices, is driving the demand for biofilm treatments, thereby enhancing market growth globally. Additionally, the increasing prevalence of biofilms is expected to further propel market expansion during the forecast period. Research indicates that biofilms are found in 60 to 100% of chronic wound samples, highlighting their rapid and widespread presence in chronic wounds, which necessitates effective treatment solutions. Technological advancements, the introduction of innovative products, and the emergence of new market players are likely to contribute to global market growth. However, challenges such as the rise of biofilm-related infections, antibiotic resistance, high costs, and limited adoption of advanced wound care products may hinder overall market progress.

Biofilms Treatment Market Overview

Factors such as increasing healthcare spending, an aging population susceptible to chronic wounds, new product introductions, and favorable reimbursement policies are driving market growth. Regulatory bodies are becoming more aware of the public health implications of biofilm-related infections, leading to the establishment of stringent regulations and guidelines aimed at preventing and treating these infections, which in turn boosts the demand for compliant biofilm treatment options. Companies are actively pursuing technological innovations to enhance biofilm treatment beyond conventional methods. These innovations may involve the creation of advanced wound dressings with enhanced antimicrobial properties, the incorporation of smart materials for biofilm detection and management, and the development of targeted drug delivery systems to address bacteria within biofilms. Furthermore, research is ongoing to leverage new technologies, including biotechnology and nanotechnology, to create more effective and efficient biofilm treatment solutions.

Strategic Insights

Biofilms Treatment Market Drivers and Opportunities

Increasing Incidence of Chronic, Surgical, and Traumatic Wounds to Favor Market

According to a study by the International Diabetes Federation, the global prevalence of diabetes was approximately 9.3% in 2024, affecting around 463 million individuals, and is projected to rise to 10.2% (about 578 million) by 2030. Biofilms also have a significant impact on the lungs and digestive systems of cystic fibrosis (CF) patients, with over 70,000 individuals affected worldwide, including around 30,000 in the US. The biofilms present in CF lungs are notably resistant to antibiotic treatment, contributing to the substantial economic burden of CF, estimated at US$ 7,509 million annually. Additionally, advancements in medical technology have led to an increase in surgical procedures, with approximately 27 million surgeries performed annually in the US, of which about 5% result in surgical site infections.

Growing Research in Emerging Economies - An Opportunity for Biofilms Treatment Market Growth

Heightened awareness of the role of microbial biofilms across various sectors is unveiling new opportunities for the development of innovative technologies in translational research aimed at mitigating their adverse effects while harnessing their benefits. Current research is focused on creating novel compounds that can be used alongside antibiotics to combat infections. Innovative strategies are essential for preventing and eliminating clinically significant infections, particularly at the nanoscale. Understanding the mechanisms by which biofilms facilitate infection and antibiotic resistance is crucial for developing effective treatment methods for infections caused by hospital-acquired pathogens. The synthesis of advanced multifunctional nanomaterials that enable simultaneous diagnosis and therapy is gaining traction in contemporary research. Progress in transcriptomics, metabolomics, and transposon-based next-generation sequencing may uncover new genetic targets for biofilm research.

Moreover, there is a pressing need to discover new antibiofilm agents that target specific components of biofilms. Research into nanoparticle-based antibiofilm agents is emerging as a promising field, particularly when multiple agents are utilized. In April 2021, MSU enhanced its biofilm research capabilities with a US$ 513,000 grant from the Murdock Trust. Consequently, ongoing studies and research are expected to positively influence biofilm treatment, creating lucrative opportunities for market growth.

Biofilms Treatment Market Report Segmentation Analysis

The biofilms treatment market analysis is segmented by product, wound type, and end user.

  • By product, the market is categorized into debridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressings segment accounted for the largest market share in 2023 and is expected to exhibit the highest CAGR during the forecast period.
  • By wound type, the market is divided into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. The traumatic and surgical wounds segment held the largest market share in 2023 and is projected to register the highest CAGR from 2023 to 2031.
  • In terms of end user, the market is segmented into hospitals, home care settings, and other end users. The hospitals segment captured the largest market share in 2023 and is anticipated to show the highest CAGR during the forecast period.

Biofilms Treatment Market Share Analysis by Geography

The geographic analysis of the biofilms treatment market is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America leads the biofilms treatment market, driven by the rising prevalence of diabetes and the presence of organizations providing wound care solutions. The biotechnology sector in North America plays a crucial role in advancing biofilms treatment. Diabetes Mellitus (DM) is recognized as having an epidemic prevalence in the US compared to global rates. As the number of diabetic patients increases, so do the associated complications. Various organizations and publications have established preferred practices for healing and closing diabetic foot ulcers (DFU). However, despite these guidelines, only 50% of DFUs heal within a year in the US. Wounds Canada, previously known as the Canadian Association of Wound Care, is a non-profit organization dedicated to advancing wound prevention and management in Canada, focusing on education, research, advocacy, and partnerships. The Mexican Association for Wound Care and Healing is a non-profit organization comprising a multidisciplinary group of specialists committed to studying wounds and stomas in Mexico, promoting comprehensive care and access to treatments to enhance patient quality of life. The Asia Pacific region is expected to experience the highest CAGR in the coming years.

Biofilms Treatment Market Report Scope

Biofilms Treatment Market News and Recent Developments

The biofilms treatment market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the biofilms treatment market include:

  • The Cystic Fibrosis Foundation invested up to US$5 million in Clarametyx Biosciences to develop CMTX-101, a drug aimed at addressing difficult-to-treat bacteria such as chronic Pseudomonas aeruginosa, a leading cause of lung infections in cystic fibrosis patients. (Cystic Fibrosis Foundation, News, 2024)
  • Trellis Bioscience Inc., a biotechnology company focused on discovering and developing native human monoclonal antibodies, announced that its lead antibody candidate, TRL1068, received Fast Track and QIDP designations from the US Food and Drug Administration (FDA). (Source: Trellis Bioscience, Inc., News, 2024)
  • Asep Medical Holdings Inc. reported the use of artificial intelligence (AI) to develop new and improved treatments for common biofilm infections and rapid diagnostics for sepsis. (Source: ASEP Medical Holdings Inc., News, 2024)
  • Medline and OMNIA Partners announced a new purchasing partnership, providing cost savings on medical-surgical product portfolios to public sector agencies, including state, county, and local governments, as well as primary and higher education systems and public safety services, allowing access to Medline's extensive portfolio of over 300,000 medical supplies. (Medline Industries, LP, Press Release, 2022)

Biofilms Treatment Market Report Coverage and Deliverables

The report titled "Biofilms Treatment Market Size and Forecast (2021-2031)" offers a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis highlighting key market trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Biofilms Treatment Market and By Product
    • 1.3.2 Global Biofilms Treatment Market and By Wound Type
    • 1.3.3 Global Biofilms Treatment Market and By End User
    • 1.3.4 Global Biofilms Treatment market and By Geography

2. Biofilms Treatment Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Biofilms Treatment and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 APAC and PEST Analysis
    • 4.2.4 Middle East and Africa and PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinions

5. Biofilms Treatment Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Chronic, Surgical, and Traumatic Wounds
    • 5.1.2 Increasing Number of Burn Injuries
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Treating Wounds
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research on Biofilm Treatment in Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Development of Novel Technologies
  • 5.5 Impact analysis

6. Biofilms Treatment Market and Global Analysis

  • 6.1 Global Biofilms Treatment Market Revenue Forecast And Analysis
  • 6.2 Global Biofilms Treatment Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Biofilms Treatment Market Analysis and By Product

  • 7.1 Overview
  • 7.2 Biofilms Treatment Market Revenue Share, by Product (2024 and 2031)
  • 7.3 Debridement Equipment
    • 7.3.1 Overview
    • 7.3.2 Debridement Equipment: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Gauzes and Dressings
    • 7.4.1 Overview
    • 7.4.2 Gauzes and Dressings: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Grafts and Matrices
    • 7.5.1 Overview
    • 7.5.2 Grafts and Matrices: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Other Products
    • 7.6.1 Overview
    • 7.6.2 Other Products: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

8. Biofilms Treatment Market Analysis and By Wound Type

  • 8.1 Overview
  • 8.2 Biofilms Treatment Market Revenue Share, by Application (2024 and 2031)
  • 8.3 Traumatic and Surgical Wounds
    • 8.3.1 Overview
    • 8.3.2 Traumatic and Surgical Wounds: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Diabetic Foot Ulcers
    • 8.4.1 Overview
    • 8.4.2 Diabetic Foot Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Pressure Ulcers
    • 8.5.1 Overview
    • 8.5.2 Pressure Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Venous Leg Ulcers
    • 8.6.1 Overview
    • 8.6.2 Venous Leg Ulcers: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Other Wounds
    • 8.7.1 Overview
    • 8.7.2 Other Wounds: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

9. Biofilms Treatment Market Analysis and By End User

  • 9.1 Overview
  • 9.2 Biofilms Treatment Market Share, by End User, 2024 and 2031, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other End Users
    • 9.5.1 Overview
    • 9.5.2 Other End Users: Biofilms Treatment Market and Revenue and Forecast to 2031 (US$ Million)

10. Biofilms Treatment Market and Geographic Analysis

  • 10.1 North America: Biofilms Treatment Market
    • 10.1.1 Overview
    • 10.1.2 North America: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.1.3 North America Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.1.4 North America Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.1.5 North America Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.6 North America: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.1.7 US: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.1 US: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.1 US Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.2 US Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.3 US Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.8 Canada: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.1 Canada: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.1 Canada Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.2 Canada Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.3 Canada Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.9 Mexico: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.1 Mexico: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.1 Mexico Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.2 Mexico Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.3 Mexico Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.2 Europe: Biofilms Treatment Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.2.3 Europe Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.2.4 Europe Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.2.5 Europe Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.6 Europe: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.2.7 Germany: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.1 Germany: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.1 Germany Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.2 Germany Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.3 Germany Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.8 France: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.1 France: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.1 France Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.2 France Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.3 France Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.9 United Kingdom: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.1 United Kingdom: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.1 United Kingdom Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.2 United Kingdom Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.3 United Kingdom Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.10 Italy: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.1 Italy: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.1 Italy Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.2 Italy Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.3 Italy Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.11 Spain: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.1 Spain: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.1 Spain Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.2 Spain Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.3 Spain Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.3 Asia Pacific: Biofilms Treatment Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
    • 10.3.3 Asia Pacific: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
    • 10.3.4 Asia Pacific: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
    • 10.3.5 Asia Pacific: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.6 Asia Pacific: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.3.7 China: Biofilms Treatment Market
      • 10.3.7.1 China: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.7.1.1 China: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.7.1.2 China: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.7.1.3 China: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.8 Japan: Biofilms Treatment Market
      • 10.3.8.1 Japan: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.8.1.1 Japan: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.8.1.2 Japan: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.8.1.3 Japan: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.9 India: Biofilms Treatment Market
      • 10.3.9.1 India: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.9.1.1 India: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.9.1.2 India: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.9.1.3 India: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.10 South Korea: Biofilms Treatment Market
      • 10.3.10.1 South Korea: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.10.1.1 South Korea: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.10.1.2 South Korea: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.10.1.3 South Korea: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
    • 10.3.11 Australia: Biofilms Treatment Market
      • 10.3.11.1 Australia: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.11.1.1 Australia: Biofilms Treatment Market, by Product, 2018-2031 (USD Millions)
        • 10.3.11.1.2 Australia: Biofilms Treatment Market, by Wound Type, 2018-2031 (USD Millions)
        • 10.3.11.1.3 Australia: Biofilms Treatment Market, by End User, 2018-2031 (USD Millions)
  • 10.4 Middle East and Africa: Biofilms Treatment Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Biofilms Treatment Market- Revenue and Forecast to 2031 (USD Million)
    • 10.4.3 Middle East and Africa Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.4.4 Middle East and Africa Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.4.5 Middle East and Africa Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.4.7 Saudi Arabia: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.1 Saudi Arabia: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.1 Saudi Arabia Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.2 Saudi Arabia Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.3 Saudi Arabia Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.8 UAE: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.1 UAE: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.1 UAE Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.2 UAE Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.3 UAE Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.9 South Africa: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.1 South Africa: Biofilms Treatment Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.1 South Africa Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.2 South Africa Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.2 South Africa Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.6 South and Central America: Biofilms Treatment Market
    • 10.6.1 Overview
    • 10.6.2 South and Central America: Biofilms Treatment Market - Revenue and Forecast to 2031 (USD Million)
    • 10.6.3 South and Central America Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.6.4 South and Central America Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
    • 10.6.5 South and Central America Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.6 South and Central America: Biofilms Treatment Market, by Country, 2024 and 2031 (%)
    • 10.6.7 Brazil: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.7.1 Brazil: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.1 Brazil Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.2 Brazil Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.3 Brazil Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.8 Argentina: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.8.1 Argentina: Biofilms Treatment Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.1 Argentina Biofilms Treatment Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.2 Argentina Biofilms Treatment Market, by Wound Type and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.3 Argentina Biofilms Treatment Market, by End User and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic On Global Biofilms Treatment Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Biofilms Treatment MarketandIndustry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. COMPANY PROFILES

  • 13.1 Smith and Nephew

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Word Index